One More Step…

Context: Afrezza Approval and Stock Surge MannKind Corporation (NASDAQ: MNKD) received FDA approval for its inhalable insulin Afrezza on June 27, 2014 (www.sec.gov). This long-awaited

Daily Financial Update Opening Recap Market Pulse: Venture capital buzz is back in AI after Paradigm’s $1.2 billion fund launch, yet that optimism was tempered

Company Overview and Recent Accolade Century Communities, Inc. (NYSE: CCS) is one of the largest U.S. homebuilders, operating across 16 states with a focus on